CareCloud shareholders approved increasing authorized shares to 85 million at a special meeting with 85% support.
Quiver AI Summary
CareCloud, Inc. announced that during its special shareholder meeting on January 27, 2025, a record 10.8 million shareholders, or 85% of votes cast, approved an amendment to increase the authorized shares of common stock from 35 million to 85 million. Co-CEO Stephen Snyder expressed gratitude for the shareholders' overwhelming support. Detailed voting results will be shared in a Form 8-K filed with the SEC. CareCloud specializes in healthcare technology and AI solutions, assisting over 40,000 providers in enhancing patient care while reducing operational costs. The press release includes forward-looking statements regarding the company's future performance and acknowledges various risks and uncertainties affecting those predictions.
Potential Positives
- Approval from 85% of shareholders for the amendment to increase authorized shares, indicating strong shareholder support and confidence in the company’s future.
- Increase in authorized shares from 35 million to 85 million, providing more flexibility for future financing and growth opportunities.
- Engagement of a record-breaking 10.8 million shareholders, reflecting heightened interest and involvement in the company's governance.
Potential Negatives
- The approval to increase authorized shares from 35 million to 85 million may dilute existing shareholders' equity, potentially leading to a decrease in share value.
- Significant shareholder participation (85% of votes) may indicate previous dissatisfaction or need for change in the company's direction or performance, raising concerns about governance.
- The press release highlights a reliance on forward-looking statements, which acknowledge substantial risks and uncertainties that could adversely impact future performance and investor confidence.
FAQ
What was approved at CareCloud's special shareholder meeting?
At the special shareholder meeting, an amendment to increase the authorized shares of common stock from 35 million to 85 million was approved.
How many shareholders participated in the meeting?
A record-breaking 10.8 million shareholders participated, representing 85% of the votes cast.
Who is the Co-CEO of CareCloud?
Stephen Snyder is the Co-Chief Executive Officer of CareCloud.
What services does CareCloud offer?
CareCloud offers solutions including revenue cycle management, practice management, electronic health records, and digital health technologies.
Where can I find more information about CareCloud's filings?
More information about CareCloud's filings can be found on the SEC’s website and at https://ir.carecloud.com/common-stock-special-proxy.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CCLD Insider Trading Activity
$CCLD insiders have traded $CCLD stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CCLD stock by insiders over the last 6 months:
- CAMERON MUNTER sold 30,000 shares for an estimated $122,999
- JOHN N DALY has made 0 purchases and 2 sales selling 15,000 shares for an estimated $55,850.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CCLD Hedge Fund Activity
We have seen 15 institutional investors add shares of $CCLD stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HERON BAY CAPITAL MANAGEMENT added 33,510 shares (+96.9%) to their portfolio in Q3 2024, for an estimated $88,466
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 29,790 shares (-11.1%) from their portfolio in Q3 2024, for an estimated $78,645
- MILLENNIUM MANAGEMENT LLC added 17,582 shares (+153.9%) to their portfolio in Q3 2024, for an estimated $46,416
- XTX TOPCO LTD added 16,012 shares (+inf%) to their portfolio in Q3 2024, for an estimated $42,271
- TWO SIGMA SECURITIES, LLC removed 13,863 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $36,598
- WEALTH EFFECTS LLC removed 12,857 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $47,056
- ENGINEERS GATE MANAGER LP added 11,921 shares (+inf%) to their portfolio in Q3 2024, for an estimated $31,471
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SOMERSET, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, today held its special meeting (“Special Meeting”) of CareCloud’s common stock shareholders. At the Special Meeting, a record-breaking 10.8 million shareholders, representing 85% of the votes cast, approved an amendment to the Company’s Certificate of Incorporation to increase the Company’s authorized shares of common stock from 35 million to 85 million shares.
“We thank our shareholders for their overwhelming support of our proposal,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud.
The detailed voting results are reflected in the Form 8-K to be filed today with the Securities and Exchange Commission (the “SEC”). Certain information contained in this press release is a summary of relevant portions of the Definitive Proxy Statement and other materials filed with the SEC. The entirety of the filings is available on the SEC’s website and on https://ir.carecloud.com/common-stock-special-proxy .
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com .
To listen to video presentations by CareCloud’s management team, read recent press releases and view our latest investor presentation, please visit ir.carecloud.com .
Follow CareCloud on LinkedIn , X and Facebook .
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE CareCloud
Company
Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
[email protected]
Investor Contact:
Stephen Snyder
Co-CEO
CareCloud, Inc.
[email protected]